The landscape of dementia prognosis has developed dramatically with the arrival of subtle biomarkers, like amyloid PET scans, tau imaging, and blood-centered exams that could detect Alzheimer's pathology years just before signs or symptoms arise. Whilst these technological improvements stand for outstanding progress in knowledge neurodegenerative h